Immunodeficiency clinical trials at UC Irvine

• Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)

  Sorry, in progress, not accepting new patients

  The purpose of the proposed study is to acquire additional data (including the assessment of anti-rHuPH20 antibodies) on the long-term safety of HYQVIA and to assess the prescribed treatment regimens and treatment administration in routine clinical practice.

  Irvine, California and other locations

Last updated: April 27, 2020